Apex Lab Solutions, LLC v. Chemisys Laboratories, LLC

Summary

The United States District Court for the District of New Jersey grants Apex Lab Solutions, LLC’s Rule 12(b)(6) motion to dismiss Chemisys Laboratories, LLC’s counterclaim. The court holds that the parties’ agreement clearly designated termination following notice and an opportunity to cure as Chemisys’s sole remedy for Apex’s nonperformance. Dismissal is entered with prejudice because amendment would be futile.

Holdings

1. The agreement expressly designated termination of the agreement for cause, following notice and an opportunity to cure, as Defendant's sole remedy for Plaintiff's nonperformance.
2. The limited remedy of termination was not so inadequate or unconscionable as to permit Defendant to pursue consequential damages or other relief outside the contractual limitation.
3. Defendant failed to state a claim for relief because the counterclaim sought remedies expressly foreclosed by the agreement's unambiguous sole-remedy provision.

Questions Presented

1. Whether the agreement's provision designating termination after notice and an opportunity to cure as Defendant's sole remedy validly limited Defendant's ability to pursue damages or other contractual relief for Plaintiff's alleged nonperformance.
2. Whether Defendant's counterclaim stated a claim for relief available under the agreement and therefore could survive a Rule 12(b)(6) motion.

Disposition

dismissed